Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

Kim, Cheong-Ju; Kyu Yoon, Hyoung; Park, Myung-Jae; Ha Yoo, Kwang; Jung, Ki-Suck; Park, Jeong-Woong; Yong Lim, Seong; Jeong Shim, Jae; Chul Lee, Yong; Sam Kim, Young; Oh, Yeon‐Mok; Yee Kim, Song; Yoo, Chul‐Gyu

doi:10.2147/copd.s128750

Public

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study

Published in International Journal of COPD • May 1, 2017

Authors:

Cheong-Ju Kim

Hyoung Kyu Yoon

Myung-Jae Park

Abstract

Background and objective: Pulmonary tuberculosis (TB) is a risk factor for chronic obstructive pulmonary disease (COPD); however, few clinical studies have investigated treatment effectiveness in COPD patients with destroyed lung by TB. The Indacaterol effectiveness in COPD patients with Tuberculosi...

Subject

Indacaterol

Medicine

COPD

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!